Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion
Clinical trial NCT02044822 · TERMINATED
Trial details
- NCT number
- NCT02044822
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-06
- Primary completion
- 2016-04-27
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.